Abstract
Infant colic, excessive crying of unknown cause, is a major burden to families and effects about 10–30 % of infants. Despite decades of research, the exact cause and treatment of infant colic has remained elusive. The use of Lactobacillus reuteri (DSM 17938) in infant colic is somewhat controversial and hence, we designed this study to evaluate its efficacy in infantile colic. We recruited predominantly or exclusively breastfed infants, aged less than 4 months in a placebo controlled observational randomized study. Participants’ were assigned to receive L. reuteri at a dose 108 colony forming units (n = 21) and placebo (n = 21). Placebo was an identical formulation without live micro-organisms. Treatment was given to subjects for 21 days and they were followed for 4 weeks. Treatment success (primary outcome), daily reduction in crying time, parent satisfaction and reduction in maternal depression (secondary outcomes) were assessed at the end of study period. Treatment success was observed in all infants (100 %) of the probiotic group while it was seen in 15.7 % of the placebo group. Mean daily crying time was more significantly reduced to 32.1 ± 8.3 min/day (P < 0.01) from 200.9 ± 6.3 min/day in the probiotic group as compared to the placebo group (120.6 ± 20.0 min/day). Moreover, throughout the study period, parent’s satisfaction and improvement in maternal depression (Edinburgh postnatal depression scale) was also significantly higher in the probiotic group. In our study population, reduction in crying time was significant (P < 0.01) even during first week of initiation of therapy. We conclude that L. reuteri (DSM 17938) reduces daily crying time and maternal depression during infantile colic. We suggest L. reuteri may be a safe and efficacious option for reducing infant colic.
Similar content being viewed by others
References
Abacı FB et al (2013) Psychosocial status and quality of life in mothers of infants with colic. Turk J Pediatr 55(4):391–395. http://www.ncbi.nlm.nih.gov/pubmed/24292032. Accessed 6 Aug 2014
Freedman SB, Al-Harthy N, Thull-Freedman J (2009) The crying infant: diagnostic testing and frequency of serious underlying disease. Pediatrics 123(3):841–848. http://www.ncbi.nlm.nih.gov/pubmed/19255012. Accessed 20 July 2014
Indrio F et al (2008) The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr 152(6):801–806. http://www.ncbi.nlm.nih.gov/pubmed/18492520. Accessed 6 Aug 2014
Iqbal MZ et al (2014) Review: probiotics and their beneficial effects against various diseases. Pak J Pharm Sci 27(2):405–415. http://www.ncbi.nlm.nih.gov/pubmed/24577933. Accessed 6 Aug 2014
Pinyerd BJ (1992) Infant colic and maternal mental health: nursing research and practice concerns. Issues Compr Pediatr Nurs 15(3):155–167. http://www.ncbi.nlm.nih.gov/pubmed/1308232. Accessed 6 Aug 2014
Radesky JS et al (2013) Inconsolable infant crying and maternal postpartum depressive symptoms. Pediatrics 131(6):e1857–e1864. http://www.ncbi.nlm.nih.gov/pubmed/23650295. Accessed 20 Dec 2014
Roberts DM, Ostapchuk M, O’Brien JG (2004) Infantile colic. Am Fam Physician 70(4):735–740. http://www.ncbi.nlm.nih.gov/pubmed/15338787. Accessed 6 Aug 2014
Savino F et al (2007). Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 119(1):e124–e130. http://www.ncbi.nlm.nih.gov/pubmed/17200238. Accessed 17 July 2014
Savino F et al (2010) Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126(3):e526–e533. http://www.ncbi.nlm.nih.gov/pubmed/20713478. Accessed 19 July 2014
Sung V et al (2012) Probiotics to improve outcomes of colic in the community: protocol for the baby biotics randomised controlled trial. BMC pediatr 12:135. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3508922&tool=pmcentrez&rendertype=abstract. Accessed 17 July 2014
Sung V et al (2014) Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ (Clin Res Ed) 348:2107. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3972414&tool=pmcentrez&rendertype=abstract. Accessed 17 July 2014
Szajewska H, Gyrczuk E, Horvath A (2013) Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 162(2):257–262. http://www.ncbi.nlm.nih.gov/pubmed/22981952. Accessed 17 July 2014
Urbańska M, Szajewska H (2014) The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Eur J Pediatr. http://www.ncbi.nlm.nih.gov/pubmed/24819885. Accessed 6 Aug 2014
Vik T et al (2009) Infantile colic, prolonged crying and maternal postnatal depression. Acta Paediatr (Oslo Nor 1992) 98(8):1344–1348. http://www.ncbi.nlm.nih.gov/pubmed/19432839. Accessed 6 Aug 2014
Walter J, Britton RA, Roos S (2011) Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc Natl Acad Sci USA 108(Suppl):4645–4652. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3063604&tool=pmcentrez&rendertype=abstract. Accessed 6 Aug 2014
Wang B et al (2010) Lactobacillus reuteri ingestion and IK(Ca) channel blockade have similar effects on rat colon motility and myenteric neurones. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 22(1):98–107, e33. http://www.ncbi.nlm.nih.gov/pubmed/19788711. Accessed 6 Aug 2014
Wessel MA et al (1954) Paroxysmal fussing in infancy, sometimes called colic. Pediatrics 14(5):421–435. http://www.ncbi.nlm.nih.gov/pubmed/13214956. Accessed 6 Aug 2014
Author information
Authors and Affiliations
Corresponding author
Additional information
Guo-Lin Mi and Lei Zhao contributed equally to this research.
Rights and permissions
About this article
Cite this article
Mi, GL., Zhao, L., Qiao, DD. et al. Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Antonie van Leeuwenhoek 107, 1547–1553 (2015). https://doi.org/10.1007/s10482-015-0448-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10482-015-0448-9